|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/724 | |
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 9/48 | |||
| A61K 31/202 |
| (11) | Number of the document | 2575487 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11790107.4 |
| Date of filing the European patent application | 2011-06-02 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/000997 |
| Date | 2011-06-02 |
| (87) | Number | WO 2011/152869 |
| Date | 2011-12-08 |
| (30) | Number | Date | Country code |
| 350804 P | 2010-06-02 | US |
| (72) |
GAINER, John, L., US
MURRAY, Robert, US
|
| (73) |
Diffusion Pharmaceuticals Llc,
2020 Avon Court 4, Charlottesville, VA 22902,
US
|
| (54) | ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS |
| ORAL FORMULATIONS OF BIPOLAR TRANS CAROTENOIDS |